The aim of this study was to evaluate whether sustained hypertensives
with high clinic blood pressure, despite multiple drug treatment, show
a true resistant hypertension or a ''white-coat effect,'' and whether
the pretreatment white-coat effect is maintained despite pharmacologi
cal therapy. The occurrence of resistant hypertension was determined i
n 250 consecutive essential hypertensives who had had an ambulatory bl
ood pressure monitoring before treatment assignment. Twenty-seven of 2
50 hypertensives with persistently high clinic blood pressure despite
3 months of adequate pharmacological therapy underwent further ambulat
ory blood pressure monitoring. Using our internal standards, seven pat
ients had a true resistant hypertension whereas 20 subjects showed a l
arge white-coat effect (white-coat resistant hypertension), ie, high c
linic blood pressure (>140/90) but ''normal'' ambulatory daytime (<139
/90 mm Hg) and 24 h (135/85 mm Hg) blood pressure. Using other cutoff
points for ambulatory blood pressure, 134/90 and 135/85 mm Hg for dayt
ime blood pressure, 10 and 13 patients, respectively, were reclassifie
d as true resistant hypertensives and 17 and 14, respectively, were wh
ite-coat resistant hypertensives. Interestingly, in white-coat resista
nt hypertensives the large differences between clinic and ambulatory d
aytime blood pressure (white-coat effect), recorded before treatment a
ssignment, were not affected by drugs and remained constant over time.
Left ventricular mass index in white-coat resistant hypertensives was
significantly lower than in truly resistant hypertensives, suggesting
that prognosis could differ between these groups. In this study, usin
g either our internal standards or some other cutoffs report-ed in the
literature, the white-coat phenomenon was an important cause of resis
tant hypertension. The use of ambulatory blood pressure monitoring in
these patients may avoid misdiagnosis of resistant hypertension, unnec
essary overtreatment, and expensive procedures to look for possible se
condary hypertension. (C) 1997 American Journal of Hypertension, Ltd.